Composite particle formulations of colistin and meropenem with improved in-vitro bacterial killing and aerosolization for inhalation.

Composite particle formulations of colistin and meropenem with improved in-vitro bacterial killing and aerosolization for inhalation.
复制标题

DOI:
10.1016/j.ijpharm.2018.07.010
复制
发表时间:
2018-09-05
影响因子:
5.8
通讯作者:
Zhou QT
Zhou QT
中科院分区:
医学2区
文献类型:
--
作者:
Mangal S;Park H;Zeng L;Yu HH;Lin YW;Velkov T;Denman JA;Zemlyanov D;Li J;Zhou QT

文献摘要

参考文献

被引文献

相似文献

Antibiotic combination therapy is promising for the treatment of lower respiratory tract infections caused by multi-drug resistant Gram-negative pathogens. Inhaled antibiotic therapy offers the advantage of direct delivery of the drugs to the site of infection, as compared to the parenteral administrations. In this study, we developed composite particle formulations of colistin and meropenem. The formulations were characterized for particle size, morphology, specific surface area, surface chemical composition, in-vitro aerosolization performance and in-vitro antibacterial activity. The combinations demonstrated enhanced antibacterial activity against clinical isolates of Acinetobacter baumannii N16870 and Pseudomonas aeruginosa 19147, when compared with antibiotic monotherapy. Spray-dried meropenem alone showed a poor aerosolization performance as indicated by a low fine particle fraction (FPF) of 32.5 ± 3.3%. Co-spraying with colistin improved the aerosolization of meropenem with up to a two-fold increase in the FPF. Such improvements in aerosolization can be attributed to the enrichment of colistin on the surface of composite particles as indicated by X-ray photoelectron spectroscopy (XPS) and time-of-flight secondary ion mass spectrometry (ToF-SIMS), and the increases in particle porosity. Intermolecular interactions between colistin and meropenem were observed for the combination formulations as measured by FT-IR. In conclusion, our results show that co-spray drying with colistin improves the antibacterial activity and aerosol performance of meropenem and produces a formulation with synergistic bacterial killing.
DOI: 10.1007/s11095-004-9020-4
发表时间: 2005-01-01
影响因子: 3.7
作者:
Chew, NYK;Tang, P;Raper, JA
通讯作者: Raper, JA
DOI: 10.1016/s0022-3549(15)00189-6
发表时间: 2016-03-01
影响因子: 3.8
作者:
Jong, Teresa;Li, Jian;Larson, Ian
通讯作者: Larson, Ian
DOI: 10.1371/journal.pone.0087825
发表时间: 2014
期刊: PloS one
影响因子: 3.7
作者:
Grasmeijer F;Lexmond AJ;van den Noort M;Hagedoorn P;Hickey AJ;Frijlink HW;de Boer AH
通讯作者: de Boer AH
DOI: 10.2174/1381612821666150820111134
发表时间: 2015-01-01
影响因子: 3.1
作者:
Lin, Yu-Wei;Wong, Jennifer;Zhou, Qi (Tony)
通讯作者: Zhou, Qi (Tony)
DOI: 10.1086/514732
发表时间: 1999-05-01
影响因子: 11.8
作者:
Levin, AS;Barone, AA;Costa, SF
通讯作者: Costa, SF